CCO Independent Conference Coverage

2005 European AIDS Conference*

November 17-20, 2005 | Dublin, Ireland

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Clinical Studies of Antiretroviral Therapy

Track 1 of 2

Faculty:

Joel E. Gallant, MD, MPHW. David Hardy, MDIan M. Sanne, MBBCH, FCP(SA)
  • Joel E. Gallant, MD, MPH
  • W. David Hardy, MD
  • Ian M. Sanne, MBBCH, FCP(SA)

Clinical Complications and Coinfections in HIV-Infected Patients

Track 2 of 2

Faculty:

William G. Powderly, MDPeter Reiss, MD, PhDJürgen K. Rockstroh, MD
  • William G. Powderly, MD
  • Peter Reiss, MD, PhD
  • Jürgen K. Rockstroh, MD

Expert Highlights (mp3)

Listen as the experts quickly summarize the most important data from this conference!

 

These audio files are in mp3 format. To listen to the audio, simply click "Download Audio." You must be logged onto the clinicaloptions.com site to listen to or download the mp3 file.

Joel E. Gallant, MD, MPH headshot

Joel E. Gallant, MD, MPH, discusses data presented at EACS on drugs with novel targets in the HIV life cycle: HIV integrase and the CCR5 coreceptor. (8 minutes)

Download Audio
W. David Hardy, MD headshot

W. David Hardy, MD, describes the findings of a trial comparing initial NRTI-sparing therapy compared with standard triple therapy and a study of immunologic responses to first-line therapy with either PI- or NNRTI-based regimens in patients who present with low CD4+ cell counts. (5 minutes)

Download Audio
Ian M. Sanne, MBBCH, FCP(SA) headshot

Ian M. Sanne, MBBCH, FCP(SA), summarizes the results of phase II studies of TMC125, an investigational NNRTI that demonstrated activity in patients with resistance to existing NNRTI agents. (6 minutes)

Download Audio

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grants provided by:

Educational grants support only the CME-certified components of this program.